GL1X · GenesisL1 explorer

UniProt Q96LI5

CCR4-NOT transcription complex subunit 6-like (Q96LI5)

CCR4-NOT transcription complex subunit 6-like (UniProt Q96LI5), EC 3.1.13.4: 11 experimental structures and 1 predicted model on GenesisL1, 3 ligands bound, 7 pockets. Binding sites, druggability and experiment against prediction…

UniProt
Q96LI5
Protein
CCR4-NOT transcription complex subunit 6-like
EC
3.1.13.4
Experimental structures
11
Predicted models
1
Ligands
3
Pockets
7 · 2 records with a druggable one

Structures

12 records of Q96LI5 in the MolNFT archive: 11 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
3NGNCrystal structure of the human CNOT6L nuclease domain in complex with AMPx-ray diffractionA——
3NGNCrystal structure of the human CNOT6L nuclease domain in complex with AMPx-ray diffractionA——
3NGOCrystal structure of the human CNOT6L nuclease domain in complex with poly(A) DNAx-ray diffractionA——
3NGOCrystal structure of the human CNOT6L nuclease domain in complex with POLY(A) DNAx-ray diffractionA——
3NGQCrystal structure of the human CNOT6L nuclease domainx-ray diffractionA——
3NGQCrystal structure of the human CNOT6L nuclease domainx-ray diffractionA——
5DV2Crystal structure of human CNOT6L in complex with cytidine-5'-monophosphatex-ray diffractionAC5P3 (best 0.57)
5DV2Crystal structure of human CNOT6L in complex with cytidine-5'- monophosphatex-ray diffractionA——
5DV4Crystal structure of human CNOT6L in complex with neomycinx-ray diffractionANMY, SO44 (best 0.57)
5DV4Crystal structure of human CNOT6L in complex with neomycinx-ray diffractionA——
7VOIStructure of the human CNOT1(MIF4G)-CNOT6L-CNOT7 complexx-ray diffractionC——
Q96LI5AlphaFold monomer V2.0 prediction for CCR4-not transcription complex subunit 6-like (Q96LI5)predictedA——

Ligands

  • C5P · Cytidine-5'-monophosphate · in 1 record
  • NMY · Neomycin · in 1 record
  • SO4 · Sulfate ion · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.